Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma

Published 2018 View Full Article

Authors

Keywords

Journal

CANCER RESEARCH

Volume 78, Issue 13 Supplement, Pages CT156-CT156

Publisher

American Association for Cancer Research (AACR)

Online

2018-08-18

DOI

10.1158/1538-7445.am2018-ct156

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CANCER RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.